A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma

Xiaolong Tang; Chumei Qi; Honghong Zhou; Yongshuo Liu

doi:10.1016/j.heliyon.2022.e10164

ScienceGate Book Chapters

JOURNAL ARTICLE

A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma

Xiaolong Tang Chumei Qi Honghong Zhou Yongshuo Liu

Year: 2022 Journal: Heliyon Vol: 8 (8)Pages: e10164-e10164 Publisher: Elsevier BV

DOI: 10.1016/j.heliyon.2022.e10164

Get Full-Text PDF Get Analytical Report

Keywords:

Immunotherapy Adenocarcinoma Immune system Signature (topology) Lung Medicine Adenocarcinoma of the lung Oncology Immunology Internal medicine Cancer research Cancer

Metrics

Cited By

6.76

FWCI (Field Weighted Citation Impact)

Refs

0.96

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Ferroptosis and cancer prognosis

Health Sciences → Medicine → Pulmonary and Respiratory Medicine

RNA modifications and cancer

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Cancer-related molecular mechanisms research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma

Metrics

Citation History

Topics

Related Documents

A Novel Metabolic-Immune Related Signature Predicts Prognosis and Immunotherapy Response in Lung Adenocarcinoma

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma

A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma

A Novel Immune‐Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma

A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma